Origin Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Origin Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-32,300	Closed	-$2.16M	–	55
2021 Q2	$2.16M	Hold	32,300	–	–	0.24%	35
2021 Q1	$2.04M	Sell	32,300 -900	-3%	-$56K	0.21%	41
2020 Q4	$2.06M	Hold	33,200	–	–	0.2%	40
2020 Q3	$2M	Sell	33,200 -43,400	-57%	-$2.61M	0.21%	33
2020 Q2	$4.5M	Sell	76,600 -6,900	-8%	-$413K	0.66%	12
2020 Q1	$4.65M	Sell	83,500 -97,000	-54%	-$5.93M	0.6%	15
2019 Q4	$11.6M	Buy	+180,500	New	+$10.3M	0.96%	23
2016 Q4	–	Sell	-97,433	Closed	-$5.25M	–	170
2016 Q3	$5.25M	Sell	97,433 -87,000	-47%	-$5.59M	0.33%	87
2016 Q2	$13.6M	Sell	184,433 -1,800	-1%	-$127K	0.91%	37
2016 Q1	$11.9M	Buy	186,233 +83,233	+81%	+$5.25M	0.83%	38
2015 Q4	$7.08M	Buy	+103,000	New	+$6.81M	0.57%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Origin Asset Management's BMY Position: Q3 2021 in Review

Origin Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 32,300 shares — an estimated $2.16M sold.

Origin Asset Management first reported a position in BMY in Q4 2015 and held it in 11 quarters. The position peaked at $13.6M in Q2 2016. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Origin Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
Origin Asset Management sold 32,300 Bristol-Myers Squibb shares in Q3 2021, an estimated $2.16M.
Origin Asset Management first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 11 quarters.
Origin Asset Management's Bristol-Myers Squibb position peaked at $13.6M in Q2 2016.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Origin Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.